FdaApplication
NDA 022282
Identifiers
- fda_app_no: NDA022282
Properties
| Property | Value |
|---|---|
| applicant_name | MATRIX LABS LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATAZANAVIR SULFATE AND RITONAVIR | ATAZANAVIR SULFATE; RITONAVIR | 300MG/100MG | TABLET;ORAL |
1 product